Randomized Clinical Trial Evaluating Differences in Postoperative Symptoms With 6Fr Percuflex Ureteral Stents Versus 6Fr Tria Ureteral Stents Versus 4.8Fr Percuflex Ureteral Stents Versus 4.8Fr Tria Ureteral Stents After Laser Lithotripsy of Renal and Ureteral Stones

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a prospective randomized controlled trial designed to assess the differences in postoperative symptoms related to placement of a 6Fr Percuflex ureteral stents, 6Fr Tria ureteral stents, 4.8Fr Percuflex ureteral stents, and 4.8Fr Tria ureteral stents after ureteroscopy with laser lithotripsy for treatment of upper tract urinary stones. 272 participants will be enrolled and will be on study for up to approximately 10 weeks.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 89
Healthy Volunteers: f
View:

• Patients with renal or ureteral urinary stones who require endoscopic treatment and stent placement in the outpatient operating room.

Locations
United States
Wisconsin
University of Wisconsin School of Medicine and Public Health
RECRUITING
Madison
Contact Information
Primary
Shuang Li
lis@urology.wisc.edu
608.263.8336
Time Frame
Start Date: 2024-03-21
Estimated Completion Date: 2026-12
Participants
Target number of participants: 272
Treatments
Active_comparator: 6Fr Percuflex ureteral stents
Active_comparator: 6Fr Tria ureteral stents
Active_comparator: 4.8Fr Tria ureteral stents
Active_comparator: 4.8Fr Percuflex ureteral stents
Related Therapeutic Areas
Sponsors
Leads: University of Wisconsin, Madison

This content was sourced from clinicaltrials.gov